ArticleClinical transplantation2026
Survival and Outcomes of Lung-Kidney and Lung-Liver Transplants Using a Large National Cohort.
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe used a national cohort to compare post-transplant outcomes of lung-kidney and lung-liver transplantation to isolated lung transplantation.
methodsThe United Network for Organ Sharing database was queried for all lung transplants performed from 1/1/2010-9/30/2024. Heart-lung and three-organ transplants were excluded. Patients undergoing isolated lung transplantation were compared with those undergoing simultaneous lung-kidney or lung-liver transplantation. Cox proportional hazards models assessed factors associated with one and three-year mortality. Temporal utilization trends were evaluated with linear regression.
resultsAmong 33,656 lung transplant recipients, 33,358 (99.1%) underwent isolated lung, 137 (0.4%) underwent lung-kidney, and 161 (0.5%) underwent lung-liver transplantation. One-year patient survival was lower for lung-kidney (79.7%) and lung-liver (82.6%) compared to lung (88.3%; log-rank p < 0.001) but not at three years (p = 0.101). Median survival was 6.3 (95% CI 6.2-6.4) years for lung, 6.2 (95% CI 4.3-10.0) years for lung-kidney, and 9.5 (95% CI 4.8-∞) years for lung-liver (log-rank p = 0.392). Following multivariable Cox risk adjustment, lung-liver was associated with increased one-year mortality (HR, 1.64; 95% CI, 1.11-2.41; p = 0.013) but not three-year mortality (HR, 1.23; 95% CI, 0.90-1.67; p = 0.187), while lung-kidney was not associated with mortality at one (p = 0.684) or three years (p = 0.162). On linear regression, the incidence of lung-kidney and lung-liver both increased over the study period at a faster rate than lung transplantation.
conclusionsAlthough lung-kidney and lung-liver had lower one-year survival, three-year survival was not different compared to isolated lung transplantation after risk adjustment. Given inferior short-term outcomes, multiorgan recipients, particularly lung-kidney, require more sensitive patient selection to ensure equitable access to abdominal allografts. However, these findings cautiously support the viability and increased utilization of multiorgan lung transplantation in carefully selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.